Flu Vaccine Efficacy Examined in Southern Hemisphere Countries
Adjusted vaccine efficacy was 36.5 percent against the predominant subtype A(H3N2) and 37.1 percent against A(H1N1)pdm09
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.